Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Get Free Report) shares traded up 10% during trading on Thursday . The stock traded as high as $8.11 and last traded at $8.2610. 18,410 shares were traded during trading, a decline of 98% from the average session volume of 873,506 shares. The stock had previously closed at $7.51.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the company. Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price target for the company in a research report on Monday, February 9th. Barclays dropped their price target on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. Finally, Weiss Ratings upgraded Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $16.00.
Check Out Our Latest Stock Report on Lumexa Imaging
Lumexa Imaging Price Performance
Insider Buying and Selling
In related news, Director Brett Brodnax acquired 35,000 shares of Lumexa Imaging stock in a transaction that occurred on Tuesday, May 19th. The shares were purchased at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the completion of the transaction, the director owned 62,027 shares in the company, valued at $449,695.75. This represents a 129.50% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.70% of the company’s stock.
Hedge Funds Weigh In On Lumexa Imaging
A number of institutional investors have recently added to or reduced their stakes in LMRI. Assetmark Inc. purchased a new position in Lumexa Imaging during the fourth quarter worth approximately $36,000. Strs Ohio purchased a new stake in Lumexa Imaging in the first quarter valued at $38,000. PNC Financial Services Group Inc. purchased a new stake in Lumexa Imaging in the first quarter valued at $63,000. State of Wyoming acquired a new position in shares of Lumexa Imaging in the 1st quarter valued at $91,000. Finally, Barclays PLC acquired a new position in shares of Lumexa Imaging in the 4th quarter valued at $133,000.
About Lumexa Imaging
We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).
Read More
- Five stocks we like better than Lumexa Imaging
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
- Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?
- The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker
- Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
